Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer.
about
Linking Medicare, Medicaid, and cancer registry data to study the burden of cancers in West Virginia.Efficacy of capecitabine-based combination therapy and single-agent capecitabine maintenance therapy in patients with metastatic breast cancerPhase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patientsComparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with opCurrent challenges of metastatic breast cancer.Evaluation of the clinical benefits of adjuvant capecitabine monotherapy in elderly women with breast cancer: A retrospective study.
P2860
Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Similar survival with single-a ...... for metastatic breast cancer.
@en
Similar survival with single-a ...... for metastatic breast cancer.
@nl
type
label
Similar survival with single-a ...... for metastatic breast cancer.
@en
Similar survival with single-a ...... for metastatic breast cancer.
@nl
prefLabel
Similar survival with single-a ...... for metastatic breast cancer.
@en
Similar survival with single-a ...... for metastatic breast cancer.
@nl
P2093
P2860
P1476
Similar survival with single-a ...... for metastatic breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10549-012-2037-1
P407
P577
2012-03-31T00:00:00Z